TY - JOUR
T1 - The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample
AU - Lawn, Will
AU - Barratt, Monica Jane
AU - Williams, Martin
AU - Horne, Abigail
AU - Winstock, Adam R
PY - 2014
Y1 - 2014
N2 - The NBOMe compounds are a novel series of hallucinogenic drugs that are potent agonists of the 5-HT2A receptor, have a short history of human consumption and are available to buy online, in most countries. In this study, we sought to investigate the patterns of use, characteristics of users and self-reported effects. A cross-sectional anonymous online survey exploring the patterns of drug use was conducted in 2012 (n = 22,289), including questions about the use of 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe and comparison drugs. We found that 2.6 of respondents (n = 582) reported having ever tried one of the three NBOMe drugs and that at 2.0 , 25I-NBOMe was the most popular (n = 442). Almost all (93.5 ) respondents whose last new drug tried was a NBOMe drug, tried it in 2012, and 81.2 of this group administered the drug orally or sublingually/buccally. Subjective effects were similar to comparison serotonergic hallucinogens, though higher negative effects while high and greater value for money were reported. The most common (41.7 ) drug source was via a website. The NBOMe drugs have emerged recently, are frequently bought using the internet and have similar effects to other hallucinogenic drugs; however, they may pose larger risks, due to the limited knowledge about them, their relatively low price and availability via the internet.
AB - The NBOMe compounds are a novel series of hallucinogenic drugs that are potent agonists of the 5-HT2A receptor, have a short history of human consumption and are available to buy online, in most countries. In this study, we sought to investigate the patterns of use, characteristics of users and self-reported effects. A cross-sectional anonymous online survey exploring the patterns of drug use was conducted in 2012 (n = 22,289), including questions about the use of 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe and comparison drugs. We found that 2.6 of respondents (n = 582) reported having ever tried one of the three NBOMe drugs and that at 2.0 , 25I-NBOMe was the most popular (n = 442). Almost all (93.5 ) respondents whose last new drug tried was a NBOMe drug, tried it in 2012, and 81.2 of this group administered the drug orally or sublingually/buccally. Subjective effects were similar to comparison serotonergic hallucinogens, though higher negative effects while high and greater value for money were reported. The most common (41.7 ) drug source was via a website. The NBOMe drugs have emerged recently, are frequently bought using the internet and have similar effects to other hallucinogenic drugs; however, they may pose larger risks, due to the limited knowledge about them, their relatively low price and availability via the internet.
UR - http://jop.sagepub.com/content/28/8/780.full.pdf+html
U2 - 10.1177/0269881114523866
DO - 10.1177/0269881114523866
M3 - Article
VL - 28
SP - 780
EP - 788
JO - Journal of Psychopharmacology
JF - Journal of Psychopharmacology
SN - 0269-8811
IS - 8
ER -